Glycine Supplementation Improves Cognitive Performance in Mexican Older Adults
Key claim: Daily 1,000 mg glycine for six months improved cognitive performance (memory and executive function) and metabolic markers related to insulin resistance and glucose metabolism in Mexican older adults.
Abstract
The purpose of this study was to evaluate the effects of daily glycine supplementation on metabolic health and cognitive performance in older adults. Over a period of six months, participants received 1,000 mg of glycine per day to determine if this amino acid could improve markers of insulin resistance, glucose metabolism, and cognitive functions such as memory and executive tasks.
The research aimed to identify whether this nutritional intervention provides a safe and effective strategy to support healthy aging, focusing on the link between metabolic balance and brain health in the elderly population.
Why this matters
Glycine is usually discussed in longevity circles as part of GlyNAC at multi-gram doses; a standalone six-month trial at just 1,000 mg/day reporting cognitive and glucose-metabolism benefits is a distinct data point that isolates the amino acid from cysteine co-supplementation. It moves glycine from a mechanism-and-combination story toward direct human outcome evidence, though the trial is early and single-population.